P53: The attractive tumor suppressor in the cancer research field

Journal of Biomedicine and Biotechnology

Volumn 2011, Issue , 2011, Pages

  Nakagawara, Akira ^a   Ozaki, Toshinori ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOCHROME C; DNA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 45; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; I KAPPA B KINASE ALPHA; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE C DELTA; PROTEIN MDM2; PROTEIN NOXA; PROTEIN P53; PROTEIN P63; PROTEIN P73; PUMA PROTEIN; SUMO 1 PROTEIN; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX2; TRANSCRIPTION FACTOR RUNX3;

APOPTOSIS; BREAST CANCER; CANCER RESEARCH; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL STRESS; CELL SURVIVAL; CELLULAR DISTRIBUTION; CHEMICAL MODIFICATION; CYTOPLASM; DNA BINDING MOTIF; DNA DAMAGE; DNA REPAIR; EXON; GENE CONTROL; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC STABILITY; HUMAN; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MOLECULAR WEIGHT; NONHUMAN; OLIGOMERIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; ANIMAL; GENETICS; METABOLISM; MOUSE; MUTATION; NEOPLASM;

ANIMALS; GENES, P53; HUMANS; MICE; MUTATION; NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79251534367     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2011/603925     Document Type: Review

References (161)

1. DeLeo A. B., Jay G., Appella E., Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse Proceedings of the National Academy of Sciences of the United States of America 1979 76 5 2420 2424
2. Kress M., May E., Cassingena R., May P., Simian virus 40-transformed cells express new species of proteins precipitable by anti-simian virus 40 tumor serum Journal of Virology 1979 31 2 472 483
3. Lane D. P., Crawford L. V., T antigen is bound to a host protein in SV40 transformed cells Nature 1979 278 5701 261 263
4. Linzer D. I. H., Levine A. J., Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40 transformed cells and uninfected embryonal carcinoma cells Cell 1979 17 1 43 52
5. Melero J. A., Stitt D. T., Mangel W. F., Carroll R. B., Identification of new polypeptide species (4855K) immunoprecipitable by antiserum to purified large T antigen and present in SV40-infected and -transformed cells Virology 1979 93 2 466 480
6. Levine A. J., Momand J., Finlay C. A., The p53 tumour suppressor gene Nature 1991 351 6326 453 456
7. Finlay C. A., Hinds P. W., Levine A. J., The p53 proto-oncogene can act as a suppressor of transformation Cell 1989 57 7 1083 1093
8. Eliyahu D., Michalovitz D., Eliyahu S., Pinhasi-Kimhi O., Oren M., Wild-type p53 can inhibit oncogene-mediated focus formation Proceedings of the National Academy of Sciences of the United States of America 1989 86 22 8763 8767
9. Baker S. J., Markowitz S., Fearon E. R., Willson J. K. V., Vogelstein B., Suppression of human colorectal carcinoma cell growth by wild-type p53 Science 1990 249 4971 912 915
10. Diller L., Kassel J., Nelson C. E., Gryka M. A., Litwak G., Gebhardt M., Bressac B., Ozturk M., Baker S. J., Vogelstein B., Friend S. H., p53 functions as a cell cycle control protein in osteosarcomas Molecular and Cellular Biology 1990 10 11 5772 5781
11. Michalovitz D., Halevy O., Oren M., Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53 Cell 1990 62 4 671 680
12. Martinez J., Georgoff I., Martinez J., Levine A. J., Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein Genes and Development 1991 5 2 151 159
13. Baker S. J., Fearon E. R., Nigro J. M., Hamilton S. R., Preisinger A. C., Jessup J. M., Van Tuinen P., Ledbetter D. H., Barker D. F., Nakamura Y., White R., Vogelstein B., Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas Science 1989 244 4901 217 221
14. Nigro J. M., Baker S. J., Preisinger A. C., Milburn Jessup J., Hostetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Devilee P., Glover T., Collins F. S., Weston A., Modali R., Harris C. C., Vogelstein B., Mutations in the p53 gene occur in diverse human tumour types Nature 1989 342 6250 705 708
15. Takahashi T., Nau M. M., Chiba I., Birrer M. J., Rosenberg R. K., Vinocour M., Levitt M., Pass H., Gazdar A. D., Minna J. D., p53: a frequent target for genetic abnormalities in lung cancer Science 1989 246 4929 491 494
16. Kelman Z., Prokocimer M., Peller S., Kahn Y., Rechavi G., Manor Y., Cohen A., Rotter V., Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia Blood 1989 74 7 2318 2324
17. Vogelstein B., Cancer. A deadly inheritance Nature 1990 348 6303 681 682
18. Iggo R., Gatter K., Bartek J., Lane D., Harris A. L., Increased expression of mutant forms of p53 oncogene in primary lung cancer Lancet 1990 335 8691 675 679
19. Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A. Jr., Butel J. S., Bradley A., Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 1992 356 6366 215 221
20. Hollstein M., Shomer B., Greenblatt M., Soussi T., Hovig E., Montesano R., Harris C. C., Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation Nucleic Acids Research 1996 24 1 141 146
21. Hollstein M., Hergenhahn M., Yang Q., Bartsch H., Wang Z.-Q., Hainaut P., New approaches to understanding p53 gene tumor mutation spectra Mutation Research 1999 431 2 199 209
22. Vousden K. H., Lu X., Live or let die: the cell's response to p53 Nature Reviews Cancer 2002 2 8 594 604
23. Cho Y., Gorina S., Jeffrey P. D., Pavletich N. P., Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations Science 1994 265 5170 346 355
24. Crawford L. V., Pim D. C., Lamb P., The cellular protein p53 in human tumours Molecular Biology and Medicine 1984 2 4 261 272
25. Cattretti G., p53 expression in breast cancer International Journal of Cancer 1986 41 178 183
26. Kern S. E., Pietenpol J. A., Thiagalingam S., Seymour A., Kinzler K. W., Vogelstein B., Oncogenic forms of p53 inhibit p53-regulated gene expression Science 1992 256 5058 827 830
27. Hachiya M., Chumakov A., Miller C. W., Akashi M., Said J., Koeffler H. P., Mutant p53 proteins behave in a dominant, negative fashion in vivo Anticancer Research 1994 14 5 1853 1859
28. Rovinski B., Benchimol S., Immortalization of rat embryo fibroblasts by the cellular p53 oncogene Oncogene 1988 2 5 445 452
29. Eliyahu D., Goldfinger N., Pinhasi-Kimhi O., Shaulsky G., Skurnik Y., Arai N., Rotter V., Oren M., Fibrosarcoma cells express two transforming mutant p53 species Oncogene 1988 3 3 313 321
30. Green M. R., When the products of oncogenes and anti-oncogenes meet Cell 1989 56 1 1 3
31. Vogelstein B., Kinzler K. W., p53 Function and dysfunction Cell 1992 70 4 523 526
32. Velculescu V. E., El-Deiry W. S., Biological and clinical importance of the p53 tumor suppressor gene Clinical Chemistry 1996 42 6 858 868
33. Vogelstein B., Lane D., Levine A. J., Surfing the p53 network Nature 2000 408 6810 307 310
34. Sionov R. V., Haupt Y., The cellular response to p53: the decision between life and death Oncogene 1999 18 45 6145 6157
35. Prives C., Hall P. A., The P53 pathway Journal of Pathology 1999 187 1 112 126
36. El-Deiry W. S., The role of p53 in chemosensitivity and radiosensitivity Oncogene 2003 22 47 7486 7495
37. Lacroix M., Toillon R.-A., Leclercq G., p53 and breast cancer, an update Endocrine-Related Cancer 2006 13 2 293 325
38. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J.-C., Valent A., Minty A., Chalon P., Lelias J.-M., Dumont X., Ferrara P., McKeon F., Caput D., Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers Cell 1997 90 4 809 819
39. Yang A., Kaghad M., Wang Y., Gillett E., Fleming M. D., Dtsch V., Andrews N. C., Caput D., McKeon F., p63, a p53 homolog at 3q2729, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Molecular Cell 1998 2 3 305 316
40. Melino G., De Laurenzi V., Vousden K. H., p73: friend or foe in tumorigenesis Nature Reviews Cancer 2002 2 8 605 615
41. Ozaki T., Nakagawara A., p73, a sophisticated p53 family member in the cancer world Cancer Science 2005 96 11 729 737
42. Irwin M. S., Kondo K., Marin M. C., Cheng L. S., Hahn W. C., Kaelin W. G. Jr., Chemosensitivity linked to p73 function Cancer Cell 2003 3 4 403 410
43. Suenaga Y., Ozaki T., Tanaka Y., Bu Y., Kamijo T., Tokuhisa T., Nakagawara A., Tamura T.-A., TATA-binding protein (TBP)-like protein is engaged in etoposide-induced apoptosis through transcriptional activation of human TAp63 gene Journal of Biological Chemistry 2009 284 51 35433 35440
44. Fabbro M., Henderson B. R., Regulation of tumor suppressors by nuclear-cytoplasmic shuttling Experimental Cell Research 2003 282 2 59 69
45. Kim I.-S., Kim D.-H., Han S.-M., Chin M.-U., Nam H.-J., Cho H.-P., Choi S.-Y., Song B.-J., Kim E.-R., Bae Y.-S., Moon Y.-H., Truncated form of importin identified in breast cancer cell inhibits nuclear import of p53 Journal of Biological Chemistry 2000 275 30 23139 23145
46. Walker K. K., Levine A. J., Identification of a novel p53 functional domain that is necessary for efficient growth suppression Proceedings of the National Academy of Sciences of the United States of America 1996 93 26 15335 15340
47. Baptiste N., Friedlander P., Chen X., Prives C., The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells Oncogene 2002 21 1 9 21
48. El-Deiry W. S., Kern S. E., Pietenpol J. A., Kinzler K. W., Vogelstein B., Definition of a consensus binding site for p53 Nature Genetics 1992 1 1 45 49
49. Pietenpol J. A., Tokino T., Thiagalingam S., El-Deiry W. S., Kinzler K. W., Vogelstein B., Sequence-specific transcriptional activation is essential for growth suppression by p53 Proceedings of the National Academy of Sciences of the United States of America 1994 91 6 1998 2002
50. Chen P.-L., Chen Y., Bookstein R., Lee W.-H., Genetic mechanisms of tumor suppression by the human p53 gene Science 1990 250 4987 1576 1580
51. Lomax M. E., Barnes D. M., Gilchrist R., Picksley S. M., Varley J. M., Camplejohn R. S., Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family Oncogene 1997 14 15 1869 1874
52. Lomax M. E., Barnes D. M., Hupp T. R., Picksley S. M., Camplejohn R. S., Characterization of p53 oligomerization domain mutations isolated from Li-Fraumeni and Li-Fraumeni like family members Oncogene 1998 17 5 643 649
53. DiGiammarino E. L., Lee A. S., Cadwell C., Zhang W., Bothner B., Ribeiro R. C., Zambeti G., Kriwacki R. W., A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer Nature Structural Biology 2002 9 1 12 16
54. Nakamura Y., Ozaki T., Niizuma H., Ohira M., Kamijo T., Nakagawara A., Functional characterization of a new p53 mutant generated by homozygous deletion in a neuroblastoma cell line Biochemical and Biophysical Research Communications 2007 354 4 892 898
55. Wiman K. G., Pharmacological reactivation of mutant p53: from protein structure to the cancer patient Oncogene 2010 29 30 4245 4252
56. El-Deiry W. S., Tokino T., Velculescu V. E., Levy D. B., Parsons R., Trent J. M., Lin D., Mercer W. E., Kinzler K. W., Vogelstein B., WAF1, a potential mediator of p53 tumor suppression Cell 1993 75 4 817 825
57. Harper J. W., Adami G. R., Wei N., Keyomarsi K., Elledge S. J., The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 1993 75 4 805 816
58. Noda A., Ning Y., Venable S. F., Pereira-Smith O. M., Smith J. R., Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen Experimental Cell Research 1994 211 1 90 98
59. Tanaka H., Arakawa H., Yamaguchi T., Shiraishi K., Fukuda S., Matsui K., Takei Y., Nakamura Y., A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage Nature 2000 404 6773 42 49
60. Kubbutat M. H. G., Jones S. N., Vousden K. H., Regulation of p53 stability by MDM2 Nature 1997 387 6630 299 303
61. Haupt Y., Maya R., Kazaz A., Oren M., MDM2 promotes the rapid degradation of p53 Nature 1997 387 6630 296 299
62. Honda R., Tanaka H., Yasuda H., Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53 FEBS Letters 1997 420 1 25 27
63. Barak Y., Juven T., Haffner R., Oren M., MDM2 expression is induced by wild type p53 activity EMBO Journal 1993 12 2 461 468
64. Selvakumaran M., Lin H.-K., Miyashita T., Wang H. G., Krajewski S., Reed J. C., Hoffman B., Liebermann D., Immediate early up-regulation of bax expression by p53 but not TGF 1: a paradigm for distinct apoptotic pathways Oncogene 1994 9 6 1791 1798
65. Green D. R., At the gates of death Cancer Cell 2006 9 5 328 330
66. Matsuda K., Yoshida K., Taya Y., Nakamura K., Nakamura Y., Arakawa H., p53AIP1 regulates the mitochondrial apoptotic pathway Cancer Research 2002 62 10 2883 2889
67. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Tokino T., Taniguchi T., Tanaka N., Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis Science 2000 288 5468 1053 1058
68. Yu J., Zhang L., Hwang P. M., Kinzler K. W., Vogelstein B., PUMA induces the rapid apoptosis of colorectal cancer cells Molecular Cell 2001 7 3 673 682
69. Nakano K., Vousden K. H., PUMA, a novel proapoptotic gene, is induced by p53 Molecular Cell 2001 7 3 683 694
70. Jeffers J. R., Parganas E., Lee Y., Yang C., Wang J., Brennan J., MacLean K. H., Han J., Chittenden T., Ihle J. N., McKinnon P. J., Cleveland J. L., Zambetti G. P., Puma is an essential mediator of p53-dependent and -independent apoptotic pathways Cancer Cell 2003 4 4 321 328
71. Rodriguez M. S., Desterro J. M. P., Lain S., Lane D. P., Hay R. T., Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation Molecular and Cellular Biology 2000 20 22 8458 8467
72. Prives C., Signaling to p53: breaking the MDM2-p53 circuit Cell 1998 95 1 5 8
73. Vassilev L. T., Vu B. T., Graves B., Carvajal D., Podlaski F., Filipovic Z., Kong N., Kammlott U., Lukacs C., Klein C., Fotouhi N., Liu E. A., In vivo activation of the p53 pathway by small-molecule antagonists of MDM2 Science 2004 303 5659 844 848
74. Kulikov R., Letienne J., Kaur M., Grossman S. R., Arts J., Blattner C., Mdm2 facilitates the association of p53 with the proteasome Proceedings of the National Academy of Sciences of the United States of America 2010 107 22 10038 10043
75. Leng R. P., Lin Y., Ma W., Wu H., Lemmers B., Chung S., Parant J. M., Lozano G., Hakem R., Benchimol S., Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation Cell 2003 112 6 779 791
76. Dornan D., Bheddah S., Newton K., Inice W., Frantz G. D., Dowd P., Koeppen H., Dixit V. M., French D. M., COP1, the negative regulator of p53, is overexpressed in breast and ovarian adenocarcinomas Cancer Research 2004 64 20 7226 7230
77. Li M., Chen D., Shiloh A., Luo J., Nikolaev A. Y., Qin J., Gu W., Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization Nature 2002 416 6881 648 653
78. Haneda M., Kojima E., Nishikimi A., Hasegawa T., Nakashima I., Isobe K.-I., Protein phosphatase 1, but not protein phosphatase 2A, dephosphorylates DNA-damaging stress-induced phospho-serine 15 of p53 FEBS Letters 2004 567 2-3 171 174
79. Li H.-H., Cai X., Shouse G. P., Piluso L. G., Liu X., A specific PP2A regulatory subunit, B56, mediates DNA damage-induced dephosphorylation of p53 at Thr55 EMBO Journal 2007 26 2 402 411
80. Khanna K. K., Keating K. E., Kozlov S., Scott S., Gatei M., Hobson K., Taya Y., Gabrielli B., Chan D., Lees-Miller S. P., Lavin M. F., ATM associates with and phosphorylates p53: mapping the region of interaction Nature Genetics 1998 20 4 398 400
81. Tibbetts R. S., Brumbaugh K. M., Williams J. M., Sarkaria J. N., Cliby W. A., Shieh S.-Y., Taya Y., Prives C., Abraham R. T., A role for ATR in the DNA damage-induced phosphorylation of p53 Genes and Development 1999 13 2 152 157
82. Goudelock D. M., Jiang K., Pereira E., Russell B., Sanchez Y., Regulatory interactions between the checkpoint kinase Chk1 and the proteins of the DNA-dependent protein kinase complex Journal of Biological Chemistry 2003 278 32 29940 29947
83. Shieh S.-Y., Taya Y., Prives C., DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization EMBO Journal 1999 18 7 1815 1823
84. Craig A., Scott M., Burch L., Smith G., Ball K., Hupp T., Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain EMBO Reports 2003 4 8 787 792
85. Xie S., Wang Q., Wu H., Cogswell J., Lu L., Jhanwar-Uniyal M., Dai W., Reactive oxygen species-induced phosphorylation of p53 on serine 20 is mediated in part by polo-like kinase-3 Journal of Biological Chemistry 2001 276 39 36194 36199
86. D'Orazi G., Cecchinelli B., Bruno T., Manni I., Higashimoto Y., Saito S., Gostissa M., Coen S., Marchetti A., Del Sal G., Piaggio G., Fanciulli M., Appella E., Soddu S., Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis Nature Cell Biology 2002 4 1 11 20
87. Yoshida K., Liu H., Miki Y., Protein kinase C regulates Ser46 phosphorylation of p53 tumor suppressor in the apoptotic response to DNA damage Journal of Biological Chemistry 2006 281 9 5734 5740
88. Herrmann C. P. E., Kraiss S., Montenarh M., Association of casein kinase II with immunopurified p53 Oncogene 1991 6 5 877 884
89. Delphin C., Huang K.-P., Scotto C., Chapel A., Vincon M., Chambaz E., Garin J., Baudier J., The in vitro phosphorylation of p53 by calcium-dependent protein kinase Ccharacterization of a protein-kinase-C-binding site on p53 European Journal of Biochemistry 1997 245 3 684 692
90. Hupp T. R., Meek D. W., Midgley C. A., Lane D. P., Regulation of the specific DNA binding function of p53 Cell 1992 71 5 875 886
91. Friend S., p53: a glimpse at the puppet behind the shadow play Science 1994 265 5170 334 335
92. Ando K., Ozaki T., Yamamoto H., Furuya K., Hosoda M., Hayashi S., Fukuzawa M., Nakagawara A., Polo-like kinase 1 (Plk1) inhibits p53 function by physical interaction and phosphorylation Journal of Biological Chemistry 2004 279 24 25549 25561
93. Shikama N., Lee C.-W., France S., Delavaine L., Lyon J., Krstic-Demonacos M., La Thangue N. B., A novel cofactor for p300 that regulates the p53 response Molecular Cell 1999 4 3 365 376
94. Sakaguchi K., Herrera J. E., Saito S., Miki T., Bustin M., Vassilev A., Anderson C. W., Appella E., DNA damage activates p53 through a phosphorylation-acetylation cascade Genes and Development 1998 12 18 2831 2841
95. Yuan Z.-M., Huang Y., Ishiko T., Nakada S., Utsugisawa T., Shioya H., Utsugisawa Y., Yokoyama K., Weichselbaum R., Shi Y., Kufe D., Role for p300 in stabilization of p53 in the response to DNA damage Journal of Biological Chemistry 1999 274 4 1883 1886
96. Michishita E., Park J. Y., Burneskis J. M., Barrett J. C., Horikawa I., Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins Molecular Biology of the Cell 2005 16 10 4623 4635
97. Kawai H., Nie L., Wiederschain D., Yuan Z.-M., Dual role of p300 in the regulation of p53 stability Journal of Biological Chemistry 2001 276 49 45928 45932
98. Grossman S. R., Deato M. E., Brignone C., Chan H. M., Kung A. L., Tagami H., Nakatani Y., Livingston D. M., Polyubiquitination of p53 by a ubiquitin ligase activity of p300 Science 2003 300 5617 342 344
99. Schmidt D., Mller S., Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity Proceedings of the National Academy of Sciences of the United States of America 2002 99 5 2872 2877
100. Wu S.-Y., Chiang C.-M., p53 sumoylation: mechanistic insights from reconstitution studies Epigenetics 2009 4 7 445 451
101. Jackson S. P., Tjian R., O-glycosylation of eukaryotic transcription factors: implications for mechanisms of transcriptional regulation Cell 1988 55 1 125 133
102. Shaw P., Freeman J., Bovey R., Iggo R., Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus Oncogene 1996 12 4 921 930
103. Reich N. C., Levine A. J., Growth regulation of a cellular tumour antigen, p53, in nontransformed cells Nature 1984 308 5955 199 201
104. Bruno T., De Nicola F., Iezzi S., Lecis D., D'Angelo C., Di Padova M., Corbi N., Dimiziani L., Zannini L., Jekimovs C., Scarsella M., Porrello A., Chersi A., Crescenzi M., Leonetti C., Khanna K. K., Soddu S., Floridi A., Passananti C., Delia D., Fanciulli M., Che-1 phosphorylation by ATM/ATR and Chk2 kinases activates p53 transcription and the G2/M checkpoint Cancer Cell 2006 10 6 473 486
105. Raman V., Tamori A., Vali M., Zeller K., Korz D., Sukumar S., HOXA5 regulates expression of the progesterone receptor Journal of Biological Chemistry 2000 275 34 26551 26555
106. Noda A., Toma-Aiba Y., Fujiwara Y., A unique, short sequence determines p53 gene basal and UV-inducible expression in normal human cells Oncogene 2000 19 1 21 31
107. Okoshi R., Ozaki T., Yamamoto H., Ando K., Koida N., Ono S., Koda T., Kamijo T., Nakagawara A., Kizaki H., Activation of AMP-activated protein kinase induces p53-dependent apoptotic cell death in response to energetic stress Journal of Biological Chemistry 2008 283 7 3979 3987
108. Hardie D. G., The AMP-activated protein kinase pathwaynew players upstream and downstream Journal of Cell Science 2004 117 23 5479 5487
109. Okoshi R., Ando K., Suenaga Y., Sang M., Kubo N., Kizaki H., Nakagawara A., Ozaki T., Transcriptional regulation of tumor suppressor p53 by cAMP-responsive element-binding protein/AMP-activated protein kinase complex in response to glucose deprivation Genes to Cells 2009 14 12 1429 1440
110. Vogan K., Bernstein M., Leclerc J.-M., Brisson L., Brossard J., Brodeur G. M., Pelletier J., Gros P., Absence of p53 gene mutations in primary neuroblastomas Cancer Research 1993 53 21 5269 5273
111. Moll U. M., LaQuaglia M., Benard J., Riou G., Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors Proceedings of the National Academy of Sciences of the United States of America 1995 92 10 4407 4411
112. Stommel J. M., Marchenko N. D., Jimenez G. S., Moll U. M., Hope T. J., Wahl G. M., A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking EMBO Journal 1999 18 6 1660 1672
113. Becker K., Marchenko N. D., Maurice M., Moll U. M., Hyperubiquitylation of wild-type p53 contributes to cytoplasmic sequestration in neuroblastoma Cell Death and Differentiation 2007 14 7 1350 1360
114. Carter S., Bischof O., Dejean A., Vousden K. H., C-terminal modifications regulate MDM2 dissociation and nuclear export of p53 Nature Cell Biology 2007 9 4 428 435
115. Nikolaev A. Y., Li M., Puskas N., Qin J., Gu W., Parc: a cytoplasmic anchor for p53 Cell 2003 112 1 29 40
116. Vitali R., Cesi V., Tanno B., Ferrari-Amorotti G., Dominici C., Calabretta B., Raschell G., Activation of p53-dependent responses in tumor cells treated with a PARC-interacting peptide Biochemical and Biophysical Research Communications 2008 368 2 350 356
117. Mihara M., Erster S., Zaika A., Petrenko O., Chittenden T., Pancoska P., Moll U. M., p53 has a direct apoptogenic role at the mitochondria Molecular Cell 2003 11 3 577 590
118. Marchenko N. D., Wolff S., Erster S., Becker K., Moll U. M., Monoubiquitylation promotes mitochondrial p53 translocation EMBO Journal 2007 26 4 923 934
119. Yin Y., Luciani M. G., Fhraeus R., p53 stability and activity is regulated by MDM2-mediated induction of alternative p53 translation products Nature Cell Biology 2002 4 6 462 467
120. Zhu J., Zhou W., Jiang J., Chen X., Identification of a novel p53 functional domain that is necessary for mediating apoptosis Journal of Biological Chemistry 1998 273 21 13030 13036
121. Venot C., Maratrat M., Sierra V., Conseiller E., Debussche L., Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains Oncogene 1999 18 14 2405 2410
122. Bourdon J.-C., Fernandes K., Murray-Zmijewski F., Liu G., Diot A., Xirodimas D. P., Saville M. K., Lane D. P., p53 isoforms can regulate p53 transcriptional activity Genes and Development 2005 19 18 2122 2137
123. Rogakou E. P., Pilch D. R., Orr A. H., Ivanova V. S., Bonner W. M., DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139 Journal of Biological Chemistry 1998 273 10 5858 5868
124. Paull T. T., Rogakou E. P., Yamazaki V., Kirchgessner C. U., Gellert M., Bonner W. M., A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage Current Biology 2000 10 15 886 895
125. Shiloh Y., ATM and related protein kinases: safeguarding genome integrity Nature Reviews Cancer 2003 3 3 155 168
126. Celeste A., Petersen S., Romanienko P. J., Fernandez-Capetillo O., Chen H. T., Sedelnikova O. A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M. J., Redon C., Pilch D. R., Olaru A., Eckhaus M., Camerini-Otero R. D., Tessarollo L., Livak F., Manova K., Bonner W. M., Nussenzweig M. C., Nussenzweig A., Genomic instability in mice lacking histone H2AX Science 2002 296 5569 922 927
127. Ozaki T., Nagase T., Ichimiya S., Seki N., Ohiri M., Nomura N., Takada N., Sakiyama S., Weber B. L., Nakagawara A., NFBD1/KIAA0170 is a novel nuclear transcriptional transactivator with BRCT domain DNA and Cell Biology 2000 19 8 475 485
128. Stewart G. S., Wang B., Bigneli C. R., Taylor A. M. R., Elledge S. J., MDC1 is a mediator of the mammalian DNA damage checkpoint Nature 2003 421 6926 961 966
129. Goldberg M., Stucki M., Falck J., D'Amours D., Rahman D., Pappin D., Bartek J., Jackson S. P., MDC1 is required for the intra-S-phase DNA damage checkpoint Nature 2003 421 6926 952 956
130. Lou Z., Minter-Dykhouse K., Wu X., Chen J., MDC1 is coupled to activated CHK2 in mammalian DNA damage response pathways Nature 2003 421 6926 957 961
131. Lou Z., Minter-Dykhouse K., Franco S., Gostissa M., Rivera M. A., Celeste A., Manis J. P., Van Deursen J., Nussenzweig A., Paull T. T., Alt F. W., Chen J., MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals Molecular Cell 2006 21 2 187 200
132. Nakanishi M., Ozaki T., Yamamoto H., Hanamoto T., Kikuchi H., Furuya K., Asaka M., Delia D., Nakagawara A., NFBD1/MDC1 associates with p53 and regulates its function at the crossroad between cell survival and death in response to DNA damage Journal of Biological Chemistry 2007 282 31 22993 23004
133. Ito Y., RUNX genes in development and cancer: regulation of viral gene expression and the discovery of RUNX family genes Advances in Cancer Research 2008 99 33 76
134. Li Q.-L., Ito K., Sakakura C., Fukamachi H., Inoue K.-I., Chi X.-Z., Lee K.-Y., Nomura S., Lee C.-W., Han S.-B., Kim H.-M., Kim W.-J., Yamamoto H., Yamashita N., Yano T., Ikeda T., Itohara S., Inazawa J., Abe T., Hagiwara A., Yamagishi H., Ooe A., Kaneda A., Sugimura T., Ushijima T., Bae S.-C., Ito Y., Causal relationship between the loss of RUNX3 expression and gastric cancer Cell 2002 109 1 113 124
135. Yamada C., Ozaki T., Ando K., Suenaga Y., Inoue K. -I., Ito Y., Okoshi R., Kageyama H., Kimura H., Miyazaki M., Nakagawara A., RUNX3 modulates DNA damage-mediated phosphorylation of tumor suppressor p53 at Ser-15 and acts as a Co-activator for p53 Journal of Biological Chemistry 2010 285 22 16693 16703
136. Pozniak C. D., Radinovic S., Yang A., McKeon F., Kaplan D. R., Miller F. D., An anti-apoptotic role for the p53 family member, p73, during developmental neuron death Science 2000 289 5477 304 306
137. Stiewe T., Zimmermann S., Frilling A., Esche H., Ptzer B. M., Transactivation-deficient TA-p73 acts as an oncogene Cancer Research 2002 62 13 3598 3602
138. Di Como C. J., Gaiddon C., Prives C., p73 function is inhibited by tumor-derived p53 mutants in mammalian cells Molecular and Cellular Biology 1999 19 2 1438 1449
139. Grob T. J., Novak U., Maisse C., Barcaroli D., Lthi A. U., Pirnia F., Hgli B., Graber H. U., De Laurenzi V., Fey M. F., Melino G., Tobler A., Human Np73 regulates a dominant negative feedback loop for TAp73 and p53 Cell Death and Differentiation 2001 8 12 1213 1223
140. Nakagawa T., Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter Molecular and Cellular Biology 2002 22 2575 2585
141. Zaika A. I., Slade N., Erster S. H., Sansome C., Joseph T. W., Pearl M., Chalas E., Moll U. M., Np73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors Journal of Experimental Medicine 2002 196 6 765 780
142. Ikawa S., Nakagawara A., Ikawa Y., p53 family genes: structural comparison, expression and mutation Cell Death and Differentiation 1999 6 12 1154 1161
143. Yang A., Walker N., Bronson R., Kaghad M., Oosterwegel M., Bonnin J., Vagner C., Bonnet H., Dikkes P., Sharpe A., McKeon F., Caput D., p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours Nature 2000 404 6773 99 103
144. Mills A. A., Zheng B., Wang X.-J., Vogel H., Roop D. R., Bradley A., p63 is a p53 homologue required for limb and epidermal morphogenesis Nature 1999 398 6729 708 713
145. Yang A., Schweitzer R., Sun D., Kaghad M., Walker N., Bronson R. T., Tabin C., Sharpe A., Caput D., Crum C., McKeon F., p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development Nature 1999 398 6729 714 718
146. Flores E. R., Sengupta S., Miller J. B., Newman J. J., Bronson R., Crowley D., Yang A., McKeon F., Jacks T., Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family Cancer Cell 2005 7 4 363 373
147. Stiewe T., Putzer B. M., Role of the p53-homologue p73 in E2F1-induced apoptosis Nature Genetics 2000 26 4 464 469
148. Irwin M., Marin M. C., Phillips A. C., Seelan R. S., Smith D. I., Liu W., Flores E. R., Tsai K. Y., Jacks T., Vousden K. H., Kaelin W. G. Jr., Role for the p53 homologue p73 in E2F-1-induced apoptosis Nature 2000 407 6804 645 648
149. Lissy N. A., Davis P. K., Irwin M., Kaelin W. G., Dowdy S. F., A common E2F-1 and p73 pathway mediates cell death induced by TCR activation Nature 2000 407 6804 642 645
150. Logotheti S., Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer FEBS Journal 2010 277 3014 3027
151. Fontemaggi G., The transcriptional repressor ZEB regulates p73 expression at the crossroad between proliferation and differentiation Molecular and Cellular Biology 2001 21 8461 8470
152. Gong J., Costanzo A., Yang H.-Q., Mellno G., Kaelin W. G. Jr., Levrero M., Wang J. Y. J., The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage Nature 1999 399 6738 806 809
153. Agami R., Blandino G., Oren M., Shaul Y., Interaction of c-Abl and p73 and their collaboration to induce apoptosis Nature 1999 399 6738 809 812
154. Yuan Z.-M., Shioya H., Ishiko T., Sun X., Gu J., Huang Y., Lu H., Kharbanda S., Weichselbaum R., Kufe D., p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage Nature 1999 399 6738 814 817
155. Ren J., Datta R., Shioya H., Li Y., Oki E., Biedermann V., Bharti A., Kufe D., p73 is regulated by protein kinase C catalytic fragment generated in the apoptotic response to DNA damage Journal of Biological Chemistry 2002 277 37 33758 33765
156. Gonzalez S., Prives C., Cordon-Cardo C., p73 regulation by Chk1 in response to DNA damage Molecular and Cellular Biology 2003 23 22 8161 8171
157. Furuya K., Ozaki T., Hanamoto T., Hosoda M., Hayashi S., Barker P. A., Takano K., Matsumoto M., Nakagawara A., Stabilization of p73 by nuclear I B kinase- mediates cisplatin-induced apoptosis Journal of Biological Chemistry 2007 282 25 18365 18378
158. Yoshida K., Ozaki T., Furuya K., Nakanishi M., Kikuchi H., Yamamoto H., Ono S., Koda T., Omura K., Nakagawara A., ATM-dependent nuclear accumulation of IKK- plays an important role in the regulation of p73-mediated apoptosis in response to cisplatin Oncogene 2008 27 8 1183 1188
159. Gaiddon C., Lokshin M., Gross I., Levasseur D., Taya Y., Loeffler J.-P., Prives C., Cyclin-dependent kinases phosphorylate p73 at Threonine 86 in a cell cycle-dependent manner and negatively regulate p73 Journal of Biological Chemistry 2003 278 30 27421 27431
160. Koida N., Ozaki T., Yamamoto H., Ono S., Koda T., Ando K., Okoshi R., Kamijo T., Omura K., Nakagawara A., Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation Journal of Biological Chemistry 2008 283 13 8555 8563
161. Komatsu S., Takenobu H., Ozaki T., Ando K., Koida N., Suenaga Y., Ichikawa T., Hishiki T., Chiba T., Iwama A., Yoshida H., Ohnuma N., Nakagawara A., Kamijo T., Plk1 regulates liver tumor cell death by phosphorylation of TAp63 Oncogene 2009 28 41 3631 3641